TBA · NSE,BSE · Multi-Specialty Hospital
Paras Healthcare IPO is scheduled to open soon . The Mainboard IPO has a price band of TBA , with a minimum lot size of TBA . .
Paras Healthcare IPO tentative timeline covering IPO opening, closing, basis of allotment, refunds, demat credit, and listing dates.
| Event | Date |
|---|---|
| IPO Open Date | TBA |
| IPO Close Date | TBA |
| Basis of Allotment | TBA |
| Initiation of Refunds | TBA |
| Credit of Shares to Demat | TBA |
| Listing Date | TBA |
Issue Size
₹1,800.00 Cr
Issue Price
[.]
Face Value
₹1/share
Market Lot
[.]
Retail Min Investment
[.]
Listing At
NSE,BSE
Sale Type
both
Fresh Issue
₹500 Cr
Offer for Sale
₹1,300 Cr
Issue Type
book building
Open Date
TBA
Close Date
TBA
Allotment
TBA
Listing
TBA
No snapshot available yet.
Dharminder Kumar Nagar is the promoter of the company.
Established in December 1987, Gurugram-headquartered Paras Healthcare Limited has built a stellar reputation as a highly dominant, clinical specialty-led healthcare provider in Northern India. Operating a sprawling network under the well-known consumer brand "Paras Health," the group has transitioned into a public limited enterprise to anchor a highly anticipated capital market debut.
The company occupies a critical role in India’s tertiary and quaternary healthcare ecosystem. Rather than concentrating solely on hyper-saturated metro markets, Paras Health strategically targets highly demanding macro-regions across five states and one union territory—including major setups in Bihar, Jharkhand, Haryana, Rajasthan, Uttar Pradesh, and Jammu & Kashmir. As of early 2026, the company operates a robust network of eight comprehensive multi-specialty hospitals with an aggregate capacity of 2,211 beds, specializing in high-acuity treatments like advanced neurology, cardiac sciences, oncology, and complex orthopedics.
Demonstrating strong operational scale, the group’s annual revenues scaled past the ₹1,600 crore milestone, paired with robust EBITDA growth driven by rising patient volumes and specialized clinical programs. As the healthcare pioneer refiles its papers for an ₹1,800 crore mainboard initial public offering to fund massive upcoming bed expansions in Ludhiana and Gurugram, it stands out as an institutional powerhouse uniquely primed to ride the structural transformation of Indian medical infrastructure.
Standalone · ₹ in Crores
| Particulars | FY Mar 2024 | FY Mar 2025 | FY Mar 2026 |
|---|---|---|---|
| Total Revenue | 1,151.02 | 1,314.21 | 1,628.78 |
| Profit After Tax (PAT) | -15.33 | -57.98 | 43.83 |
| EBITDA | 154.41 | 156.46 | 335.58 |
| Total Assets | 1,477.66 | 1,810.45 | 2,071.14 |
| Net Worth | 338.51 | 280.49 | 394.94 |
| Reserves & Surplus | 328.75 | 270.73 | 384.84 |
| Total Borrowing | 547.53 | 727.93 | 854.1 |
Revenue & Profit Trend
Key ratios per fiscal period
| Particulars | Mar 2026 |
|---|---|
| RoE Return on Equity Shows how much profit the company makes on the money shareholders have put in. 15% to 20% is healthy in most industries. | 12.98% |
| RoCE Return on Capital Employed Shows the profit earned on all the money used, shareholder funds plus loans. Matters most for factory and infrastructure heavy companies. | 10.76% |
| RoNW Return on Net Worth Shows the profit earned on the company's own net worth. Steady or rising over 3 years is a good sign. | 12.98% |
| PAT Margin Profit After Tax Margin Out of every ₹100 of sales, how much the company keeps after paying all costs, loan interest and tax. | 2.69% |
| EBITDA Margin Earnings Before Interest, Tax, Depreciation and Amortisation Margin Profit from the main business as a share of sales, before loan interest and tax. Compare it with other companies in the same industry. | 20.6% |
| Debt / Equity Debt to Equity How much the company has borrowed against what shareholders own. Above 1x means the loans are bigger than shareholder funds. | 3.53x |
Issue-level · at the upper price band
| Particulars | Pre-IPO | Post-IPO |
|---|---|---|
| EPS Earnings Per Share Profit the company earns on each share. Post-IPO EPS is usually lower because the issue adds new shares. | ₹4.34 | - |
The allotment date for Paras Healthcare IPO will be announced after the subscription closes. You can check your allotment status using your PAN number or application number on the MUFG Intime India Pvt.Ltd portal or BSE.
The Paras Healthcare IPO dates are coming soon. The subscription dates will be announced officially by the company and updated here once finalized.
The price band for Paras Healthcare IPO is yet to be announced.
As per market sources, Paras Healthcare IPO GMP is tracked daily in the grey market. GMP indicates unofficial demand but does not guarantee listing gains.
The subscription status for Paras Healthcare IPO is being updated. Check the latest subscription figures by category (Retail, QIB, NII) for real-time updates.
The listing date for Paras Healthcare IPO is yet to be announced and will be updated once finalized.
No comments yet. Be the first to comment!